State Street’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.1M | Buy |
1,424,544
+113,903
| +9% | +$4.82M | ﹤0.01% | 1771 |
|
|
2025
Q4 | $60.7M | Buy |
1,310,641
+16,730
| +1% | +$700K | ﹤0.01% | 1636 |
|
|
2025
Q3 | $45.3M | Sell |
1,293,911
-60,506
| -4% | -$2.1M | ﹤0.01% | 1774 |
|
|
2025
Q2 | $40.1M | Sell |
1,354,417
-20,588
| -1% | -$587K | ﹤0.01% | 1795 |
|
|
2025
Q1 | $41M | Sell |
1,375,005
-62,149
| -4% | -$1.9M | ﹤0.01% | 1743 |
|
|
2024
Q4 | $41.2M | Buy |
1,437,154
+63,828
| +5% | +$2.11M | ﹤0.01% | 1822 |
|
|
2024
Q3 | $53.1M | Sell |
1,373,326
-6,627
| -0.5% | -$236K | ﹤0.01% | 1681 |
|
|
2024
Q2 | $44.4M | Buy |
1,379,953
+60,898
| +5% | +$2.11M | ﹤0.01% | 1730 |
|
|
2024
Q1 | $51.2M | Buy |
1,319,055
+5,180
| +0.4% | +$181K | ﹤0.01% | 1717 |
|
|
2023
Q4 | $40.4M | Buy |
1,313,875
+23,379
| +2% | +$586K | ﹤0.01% | 1824 |
|
|
2023
Q3 | $28.8M | Buy |
1,290,496
+23,027
| +2% | +$525K | ﹤0.01% | 1942 |
|
|
2023
Q2 | $27.2M | Sell |
1,267,469
-85,223
| -6% | -$1.93M | ﹤0.01% | 2044 |
|
|
2023
Q1 | $32.5M | Buy |
1,352,692
+64,478
| +5% | +$1.71M | ﹤0.01% | 1917 |
|
|
2022
Q4 | $29.9M | Sell |
1,288,214
-74,448
| -5% | -$1.5M | ﹤0.01% | 1966 |
|
|
2022
Q3 | $21.8M | Sell |
1,362,662
-28,031
| -2% | -$494K | ﹤0.01% | 2155 |
|
|
2022
Q2 | $24.6M | Buy |
1,390,693
+82,526
| +6% | +$1.39M | ﹤0.01% | 2102 |
|
|
2022
Q1 | $26.6M | Buy |
1,308,167
+165,144
| +14% | +$3.12M | ﹤0.01% | 2186 |
|
|
2021
Q4 | $21.4M | Sell |
1,143,023
-8,639
| -0.8% | -$168K | ﹤0.01% | 2436 |
|
|
2021
Q3 | $22.7M | Sell |
1,151,662
-2,761
| -0.2% | -$59.7K | ﹤0.01% | 2387 |
|
|
2021
Q2 | $27.3M | Buy |
1,154,423
+58,221
| +5% | +$1.34M | ﹤0.01% | 2309 |
|
|
2021
Q1 | $26M | Buy |
1,096,202
+332,734
| +44% | +$7.9M | ﹤0.01% | 2195 |
|
|
2020
Q4 | $15.3M | Buy |
763,468
+10,907
| +1% | +$213K | ﹤0.01% | 2393 |
|
|
2020
Q3 | $15.7M | Sell |
752,561
-62,582
| -8% | -$1.13M | ﹤0.01% | 2173 |
|
|
2020
Q2 | $14.3M | Buy |
815,143
+105,337
| +15% | +$2.06M | ﹤0.01% | 2219 |
|
|
2020
Q1 | $11.6M | Sell |
709,806
-15,357
| -2% | -$317K | ﹤0.01% | 2192 |
|
|
2019
Q4 | $14.9M | Buy |
725,163
+29,126
| +4% | +$485K | ﹤0.01% | 2324 |
|
|
2019
Q3 | $7.99M | Buy |
696,037
+19,721
| +3% | +$225K | ﹤0.01% | 2576 |
|
|
2019
Q2 | $8.89M | Buy |
676,316
+30,149
| +5% | +$403K | ﹤0.01% | 2563 |
|
|
2019
Q1 | $9.78M | Buy |
646,167
+8,555
| +1% | +$137K | ﹤0.01% | 2480 |
|
|
2018
Q4 | $10.9M | Sell |
637,612
-144,983
| -19% | -$2.48M | ﹤0.01% | 2384 |
|
|
2018
Q3 | $11.5M | Buy |
782,595
+130,679
| +20% | +$2.32M | ﹤0.01% | 2501 |
|
|
2018
Q2 | $15.6M | Buy |
651,916
+43,341
| +7% | +$1.07M | ﹤0.01% | 2306 |
|
|
2018
Q1 | $15.6M | Buy |
608,575
+246,953
| +68% | +$5.88M | ﹤0.01% | 2217 |
|
|
2017
Q4 | $6.68M | Buy |
361,622
+37,156
| +11% | +$532K | ﹤0.01% | 2655 |
|
|
2017
Q3 | $3.4M | Buy |
324,466
+3,126
| +1% | +$34.5K | ﹤0.01% | 2970 |
|
|
2017
Q2 | $4.03M | Buy |
321,340
+48,236
| +18% | +$477K | ﹤0.01% | 2846 |
|
|
2017
Q1 | $2.75M | Sell |
273,104
-16,115
| -6% | -$240K | ﹤0.01% | 2970 |
|
|
2016
Q4 | $4.53M | Buy |
289,219
+91,287
| +46% | +$1.52M | ﹤0.01% | 2749 |
|
|
2016
Q3 | $3.81M | Buy |
197,932
+20,935
| +12% | +$249K | ﹤0.01% | 2714 |
|
|
2016
Q2 | $2.1M | Buy |
176,997
+66,424
| +60% | +$1.1M | ﹤0.01% | 3011 |
|
|
2016
Q1 | $2.01M | Buy |
110,573
+34,708
| +46% | +$631K | ﹤0.01% | 3003 |
|
|
2015
Q4 | $2.09M | Buy |
75,865
+4,435
| +6% | +$93.4K | ﹤0.01% | 2979 |
|
|
2015
Q3 | $1.58M | Buy |
71,430
+26,924
| +60% | +$487K | ﹤0.01% | 3082 |
|
|
2015
Q2 | $794K | Buy |
+44,506
| New | +$770K | ﹤0.01% | 3294 |
|
Other funds holding COLL
EAM
VCM
RCMNY
State Street's COLL Position: Q1 2026 in Review
State Street increased its Collegium Pharmaceutical (COLL) stake by 8.7% in Q1 2026, buying an estimated $4.82M and bringing the position to 1,424,544 shares worth $47.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1771.
State Street first reported a position in COLL in Q2 2015 and has held it in 44 quarters since. The position peaked at $60.7M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- State Street held 1,424,544 shares of Collegium Pharmaceutical worth $47.1M as of Q1 2026.
- State Street bought 113,903 Collegium Pharmaceutical shares in Q1 2026, an estimated $4.82M.
- Collegium Pharmaceutical made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1771 holding.
- State Street first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 44 quarters since.
- State Street's Collegium Pharmaceutical position peaked at $60.7M in Q4 2025.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.